Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Invest New Drugs. 2012 Apr 11;31(1):136–144. doi: 10.1007/s10637-012-9815-9

Fig. 4.

Fig. 4

Change in Tumor Size at Best Response by Dose is presented as waterfall plot of dose-dependent mean change in tumor size at best response. The waterfall plot uses target lesion measurements only. †Three patients with response data are not included in the waterfall plot due to incomplete lesion assessments at post baseline visits. Patient 2 in LY 40 mg/m2 cohort, patient 1 in the LY 70 mg/m2 cohort, and patients 3, 4, and 5 in LY 105 mg/m2 cohort had progressive disease due to the appearance of non-target lesions. Numbers of days on study are indicated above/below each bar